Goldman Sachs
-
Voters rewarded a five year dollar print from Finnvera — the first in that tenor from a European SSA since March — with strong scores across the board. -
Deutsche Bank shares were up nearly 4% on Friday morning, following confirmation on Thursday evening that the Federal Reserve had failed the Comprehensive Capital Analysis and Review submission from its DB USA unit on qualitative grounds. The Fed also blocked planned payout boosts from Goldman Sachs and Morgan Stanley.
-
China Tower Corp is set to begin premarketing its Hong Kong IPO next week, after winning listing approval on Thursday for what is expected to be a $10bn deal, according to a source close to trade.
-
Hong Kong’s new biotechnology-friendly listing regime attracted IPO filings this week from China-based Innovent Biologics and MicuRx Pharmaceuticals.
-
Health and Happiness International Holdings, previously known as Biostime International Holdings, is seeking an up to $350m loan through Goldman Sachs.
-
-
JP Morgan has hired Tobias Heilmaier, Goldman Sachs’ former head of chemicals for EMEA, as co-head of corporate finance coverage in Germany, a newly created role. Michele Iozzolino, who has been with the firm since 2005, will be the other co-head.
-
Beijing-based investment bank Chinese Renaissance has set the ball rolling on its Hong Kong IPO.
-
Chinese technology unicorn Meituan Dianping is seeking an IPO in Hong Kong that could raise upwards of $4bn.
-
Qeeka Home delayed its HK$2.18bn ($277.6m) IPO indefinitely this week as fears grew about a trade war between the US and China.
-
Qeeka Home is delaying its HK$2.18bn ($277.6m) IPO in Hong Kong indefinitely as fears grow about a trade war between the US and China.
-
China Huarong Asset Management Co focused on getting a sensible price rather than a large size with its Tuesday bond issue, raising $1.1bn from three tranches. The deal followed a probe of its former chairman earlier this year, as well as a general widening of bonds from the sector.
